Literature DB >> 8282792

Hepatitis B virus persistence after recovery from acute viral hepatitis.

T I Michalak1, C Pasquinelli, S Guilhot, F V Chisari.   

Abstract

Contrary to current opinion, the disappearance of hepatitis B surface antigen (HBsAg) from the serum, the development of anti-HBs antibodies, and normalization of liver function may not reflect complete virological recovery from acute hepatitis B virus (HBV) infection. By using the polymerase chain reaction (PCR), in the current study we demonstrate long-term persistence of HBV DNA in the serum and peripheral blood mononuclear cells (PBMC) of four patients for up to 70 mo after complete clinical, biochemical, and serological recovery from acute viral hepatitis. Serum HBV DNA reactivity co-sedimented with HBsAg in sucrose gradients, and it displayed the size and density characteristics of naked core particles and intact HBV virions, presumably contained within circulating immune complexes in these anti-HBs antibody-positive sera. HBV DNA was also present in PBMC in late convalescent samples from all four patients, and HBV RNA was detected in late convalescent phase PBMC in two of these patients. These results suggest that HBV DNA, and possibly HBV virions, can be present in the serum, and that the viral genome can persist in a transcriptionally active form in PBMC for > 5 yr after complete clinical and serological recovery from acute viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282792      PMCID: PMC293757          DOI: 10.1172/JCI116950

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Clearance of HBsAg in seven patients with chronic hepatitis B.

Authors:  H Adachi; S Kaneko; E Matsushita; Y Inagaki; M Unoura; K Kobayashi
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

2.  Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.

Authors:  J Xu; D Brown; T Harrison; Y Lin; G Dusheiko
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

3.  Demonstration of subpopulations of Dane particles.

Authors:  P M Kaplan; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

4.  Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice.

Authors:  P N Gilles; G Fey; F V Chisari
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Complete nucleotide sequence of the Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1979

6.  Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance.

Authors:  A Mason; B Yoffe; C Noonan; M Mearns; C Campbell; A Kelley; R P Perrillo
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

7.  Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver.

Authors:  J Molina; J Bartolomé; G Moraleda; M Ruiz-Moreno; M J Rua; A Moreno; V Carreño
Journal:  J Med Virol       Date:  1992-09       Impact factor: 2.327

8.  Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen.

Authors:  M Kuhns; A McNamara; A Mason; C Campbell; R Perrillo
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

9.  Viral hepatitis, type B. Studies on natural history and prevention re-examined.

Authors:  S Krugman; L R Overby; I K Mushahwar; C M Ling; G G Frösner; F Deinhardt
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

10.  In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes.

Authors:  B E Korba; P J Cote; M Shapiro; R H Purcell; J L Gerin
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

View more
  66 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

3.  [Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis].

Authors:  B Rehermann; K Klugewitz; U Seifert; K H Böker; S Wagner; M P Manns
Journal:  Med Klin (Munich)       Date:  1997-07-15

4.  Identification of different states of hepatitis B virus infection with a quantitative PCR assay.

Authors:  H H Kessler; S Preininger; E Stelzl; E Daghofer; B I Santner; E Marth; H Lackner; R E Stauber
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 5.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 6.  Hepatitis B in 2014: HBV research moves forward--receptors and reactivation.

Authors:  Man-Fung Yuen; Ching-Lung Lai
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-16       Impact factor: 46.802

7.  Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.

Authors:  C S Coffin; P M Mulrooney-Cousins; M G Peters; G van Marle; J P Roberts; T I Michalak; N A Terrault
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

8.  Real Time-PCR HBV-DNA Analysis: Significance and First Experience in Armed Forces.

Authors:  G S Chopra; P K Gupta; A C Anand; P P Varma; V Nair; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2011-05-30

9.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.

Authors:  B Rehermann; C Pasquinelli; S M Mosier; F V Chisari
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.